◢ SPACE MEDICINE FOUNDATION
⌕ Search
Space weather
Geomagnetic storm level: Loading…
Solar radiation level: Loading…
Updated --:-- -- ET · educational only
EDUCATIONAL RESOURCE · Educational use only — not medical advice and not operational guidance. Disclaimer

Home › Learn › Case files › In-flight kidney stone

AI-assisted content for educational use only; not medical advice and not operational guidance. Reviewed: clinical review Oct 14, 2026 (AI-assisted), by an AI medical research assistant, not a named human clinician. Items marked “pending verification” could not be confirmed against a primary source. Disclaimer

Fictional composite case

This case is invented for teaching. It combines typical features from the cited sources and describes no real astronaut, spaceflight participant or patient. No real patient data were used.

LRN-24 · Teaching case (fictional) · Learn

Case File: Flank Pain in Month Five

Gravity FieldsDistance from EarthHostile/Closed EnvironmentRenal & GUMusculoskeletalIn-flightLEO long-durationMars transit & surfaceLunar surfaceClinicianOperator / Spaceflight participant

AI-assisted Last reviewed: 2026-10-14 · Reviewer: AI-assisted clinical review (AI medical research assistant; no named human clinician)

Bottom line
  • Spaceflight raises stone risk through bone calcium loss and lower urine volume [1]. ◆◆◆◆ High · F
  • No symptomatic stones have been reported in U.S. ISS crew to date, but risk after flight is estimated at 2–7 times preflight [1]. ◆◆◇◇ Low · F C
  • Prevention is mainly fluids; potassium citrate reduced risk markers in a flight study [1][10]. ◆◆◆◇ Moderate · F C

Proposed certainty (◆ High → ◇ Very low) and evidence-type tags: F flight · A analog · M model/animal · C computational · E expert/operational/standards. AI-proposed, pending reviewer confirmation. How to read the grades.

Presentation

In month 5 of a 6-month mission, a 44-year-old crewmember develops sudden, severe left flank pain that comes in waves and spreads toward the groin. He is nauseated and has vomited once. A crew medical officer (CMO), who is not a physician, examines him with the ground flight surgeon on a video link.

  • Background: one kidney stone at age 30, disclosed before flight. His logged fluid intake has averaged about 1.5 L a day.
  • Findings: no fever. Urine dipstick shows blood.
  • Equipment on board: ultrasound, pain and nausea medicines, intravenous fluids.

Questions

  1. Why is the risk of kidney stones higher in spaceflight?
  2. How would the diagnosis be made on board?
  3. What is the key management decision?
  4. How could this have been prevented?

Think through your answers before opening the reveals below.

Reveal

Question 1: answer and discussion

Why is the risk of kidney stones higher in spaceflight?

  • Bone loss releases calcium, which is excreted in the urine [1][2].
  • Less urine. In long-duration crew, urine volume was 47% lower before flight day 30 and 39% lower after flight day 60 [1].
  • Urine chemistry. Supersaturation of stone-forming salts (brushite and calcium oxalate) rose during flight [1][2].
  • A prior symptomatic stone is a clear personal risk factor [1].
Question 2: answer and discussion

How would the diagnosis be made on board?

With ultrasound, which is NASA’s in-flight diagnostic tool for this problem [1]. A non-physician crewmember can obtain usable images when guided in real time by experts on the ground. See point-of-care ultrasound. Look for:

  • a visible stone at the junction of kidney and ureter or in the renal pelvis;
  • swelling of the collecting system on the painful side (hydronephrosis), if enough time has passed for it to develop;
  • a missing urine jet into the bladder from the ureter on the painful side [1].

NASA notes an open question: whether ultrasound criteria work the same way in flight. For example, cabin carbon dioxide may weaken the “twinkle” artifact used to spot stones [1]. On Earth, never delay a clinically needed CT scan; if he were on the ground with a suspected infected, blocked kidney and a non-diagnostic ultrasound, CT would be appropriate.

Question 3: answer and discussion

What is the key management decision?

First, treat. Medicines on the International Space Station for this problem, per NASA’s 2024 evidence report, include [1]:

  • Pain: ketorolac and ibuprofen (anti-inflammatory drugs, or NSAIDs), and hydromorphone (an opioid).
  • Nausea: ondansetron and promethazine.
  • Stone passage: tamsulosin.
  • Infection: antibiotics such as trimethoprim-sulfamethoxazole.

European urology guidance makes an NSAID the first drug of choice and an opioid the second choice [3]. Ketorolac is contraindicated in advanced kidney impairment and in people at risk of kidney failure from volume depletion, so correct dehydration first [4]. Tamsulosin helps mainly with larger stones: in a meta-analysis of randomized trials, it improved passage of 5–10 mm stones (number needed to treat 5) but not smaller ones; pooled passage was 85% vs 66% overall [5][3]. Do not force fluids during acute colic. A Cochrane review found no reliable evidence that high-volume fluids help stones pass [6]. Give fluids to replace what he has lost through vomiting.

Then decide: manage on board, or decompress? On Earth, these findings mean urgent drainage of the kidney (a ureteral stent or a nephrostomy tube) [3]:

  • fever or other signs of infection with a blocked kidney (a urological emergency: drain urgently and start antibiotics immediately) [3];
  • a blocked solitary kidney, both sides blocked, little or no urine, or rising creatinine (kidney function failing) [3];
  • pain or vomiting that cannot be controlled [3].

Nitrofurantoin is not a treatment for a kidney infection: European guidance says not to use it for pyelonephritis [7]. In low Earth orbit, any of these findings means evacuation for definitive care on Earth [1][8]. On a Mars mission there would be no evacuation, so ultrasound and drugs on board must be enough [1].

Research gaps, not current capability:

  • Ultrasonic propulsion (pushing a stone with focused ultrasound): stones moved in 14 of 15 people in a first human trial; NASA rates the technology readiness level at 5–6 [9][1].
  • Percutaneous nephrostomy (a drain placed through the back into the kidney): NASA notes evidence for autonomous use in flight is thin; in low Earth orbit the condition would likely lead to evacuation [1].

For context: NASA reports no symptomatic kidney stones in U.S. ISS crew to date, and one possible episode in a cosmonaut [1].

Question 4: answer and discussion

How could this have been prevented?

  • Fluids. Stone risk rises when urine output falls below 1.5 L a day. A NASA model suggests in-flight water intake would need to rise to about 3.2 L a day to bring calcium oxalate risk back to preflight levels [1]. That is a prevention target; during acute colic, give fluids only to replace losses [6].

  • Potassium citrate. In a flight study of 30 crewmembers, 20 mEq a day reduced calcium oxalate risk markers [10].

  • Diet. Limit sodium and animal protein [1].

  • Protect bone with resistance exercise, which reduces the calcium released into urine [1].

  • Screen the urine before flight. NASA assesses crew with a 24-hour urine stone-risk profile, NASA’s Renal Stone Risk Index (RSRI). In a retrospective review, a high RSRI correlated strongly (0.93) with known stone-formers; NASA performs it annually and after flight [1].

With his stone history, a preflight urology review and 24-hour urine test would have been reasonable; see kidney stone risk.

Teaching points

  • Bone loss plus low urine volume makes spaceflight a stone-forming environment [1].
  • Ultrasound, operated by crew with remote guidance, is the in-flight diagnostic tool [1].
  • Distance changes the decision: evacuation is possible from low Earth orbit, but not from a Mars transit [8][1].
  • Hydration is the main countermeasure; citrate is an option for high-risk crew [1][10].
  • During acute colic: NSAID first, opioid second, fluids only to replace losses; fever with a blocked kidney means urgent drainage on Earth and evacuation from orbit [3][6][1].
  • Stone risk may stay higher after return: one modelling review estimated 2–7 times the preflight rate in the first year, with wide uncertainty, and many stones occur years later [1].

Read more

Evidence profile
Overall certainty
◆◆◇◇ Low (proposed)
Evidence types
F · Flight dataC · ComputationalE · Expert / operational / standards
Literature through
2026-10-14
Case data
Fictional composite; no real patient data
Credit
Educational only; no CME or other credit
Requirements referenced 4
RequirementTitlePlain-language meaning
[V1 3004]In-Mission Medical CareTraining, capabilities and resources to diagnose and treat conditions, based on risk assessment and mission constraints.
[V1 3007]Medical EvacuationEvacuation to a higher level of care for conditions beyond onboard capability; preservation of life comes first.
[V1 4019]–[V1 4020]Nutritional Status / In-Mission Nutrient IntakeDiet assessed and must meet 100% of nutrient and energy needs.
[V2 7045]Medical Equipment UsabilityMedical equipment usable by non-physicians.

IDs as published in NASA-STD-3001 Vol. 1 Rev C (2023-09-15) and NASA-STD-3001 Vol. 2 Rev F (2026-07-14). NASA-STD-3001 binds NASA programs; it is not a regulation for commercial flights. Paraphrased. Standards quick reference.

References 10
  1. NASA Human Research Program. Evidence Report: Risk of Renal Stone Formation (2024). humanresearchroadmap.nasa.gov/evidence/other/2024%20Renal%20… NASA F
  2. Smith SM, Heer M, Shackelford LC, et al. Bone metabolism and renal stone risk during International Space Station missions. Bone. 2015;81:712–720. doi:10.1016/j.bone.2015.10.002 PMID:26456109 Peer-reviewed F
  3. European Association of Urology. EAU Guidelines on Urolithiasis: renal colic, sepsis/anuria in the obstructed kidney, medical expulsive therapy (online guideline, read 2026-10-14). uroweb.org/guidelines/urolithiasis/chapter/guidelines Organization / other E
  4. Ketorolac tromethamine injection, U.S. prescribing information (boxed warning: renal risk). DailyMed, read 2026-10-14. dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6758cb38-dec8… Organization / other E
  5. Wang RC, Smith-Bindman R, Whitaker E, et al. Effect of tamsulosin on stone passage for ureteral stones: a systematic review and meta-analysis. Ann Emerg Med. 2017;69(3):353–361.e3. doi:10.1016/j.annemergmed.2016.06.044 PMID:27616037 Peer-reviewed E
  6. Worster AS, Bhanich Supapol W. Fluids and diuretics for acute ureteric colic. Cochrane Database Syst Rev. 2012;(2):CD004926. doi:10.1002/14651858.CD004926.pub3 PMID:22336806 Peer-reviewed E
  7. European Association of Urology. EAU Guidelines on Urological Infections: pyelonephritis (online guideline, read 2026-10-14). uroweb.org/guidelines/urological-infections/chapter/the-guid… Organization / other E
  8. NASA OCHMO. NASA-STD-3001, Volume 1: Crew Health, Revision C (2023). www.nasa.gov/wp-content/uploads/2023/11/nasa-std-3001-vol-1-… Standard E
  9. Harper JD, Cunitz BW, Dunmire B, et al. First in human clinical trial of ultrasonic propulsion of kidney stones. J Urol. 2016;195(4 Pt 1):956–964. doi:10.1016/j.juro.2015.10.131 PMID:26521719 Peer-reviewed A
  10. Whitson PA, Pietrzyk RA, Jones JA, Nelman-Gonzalez M, Hudson EK, Sams CF. Effect of potassium citrate therapy on the risk of renal stone formation during spaceflight. J Urol. 2009;182(5):2490–2496. doi:10.1016/j.juro.2009.07.010 PMID:19765769 Peer-reviewed F

Machine-checked on 2026-10-14: each URL was fetched, each DOI's title/journal/year matched via Crossref, PubMed IDs matched to DOIs, and claims were checked against the source text (abstract, NASA document or official web page). Human verification against full text is still required before review. NASA documents are U.S. Government works (public domain) and are summarized with attribution; journal articles are summarized, not reproduced.

Article info
Authors
Pending (AI-assisted)
Reviewer
AI-assisted clinical review (AI medical research assistant; no named human clinician)
Last reviewed
2026-10-14
Literature through
2026-10-14
AI-assisted
Yes (disclosed)
COI
Pending
License
CC BY-SA 4.0
Use
Educational only · no CME credit · Disclaimer
Cite this version
Pending first edition

Educational use only · not medical advice · Disclaimer · CC BY-SA 4.0

Search and quick actions

Type to search. Use the up and down arrow keys to move through results, Enter to open, Escape to close.